In turn, among patients with delayed-type hypersensitivity, the level of interleukin 1 beta was significantly (p < 0,05) higher when compared to the control group and significantly (p < 0.05) lower in comparison with IgE-mediated allergy patients. This evidence concerns the gene IL1B and allergic disease.